TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nirvana Health Lab AB
Closing information (x1000 EUR)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
63
|
68
|
56 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
3
|
-1
|
-12 |
| EBITDA |
4
|
-1
|
-11 |
| Total assets |
23
|
40
|
35 |
| Current assets |
20
|
35
|
30 |
| Current liabilities |
3
|
15
|
13 |
| Equity capital |
7
|
5
|
5 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
30.4%
|
12.5%
|
14.3% |
| Turnover per employee |
68
|
56 | |
| Profit as a percentage of turnover |
4.8%
|
-1.5%
|
-21.4% |
| Return on assets (ROA) |
13.0%
|
-2.5%
|
-34.3% |
| Current ratio |
666.7%
|
233.3%
|
230.8% |
| Return on equity (ROE) |
42.9%
|
-20.0%
|
-240.0% |
| Change turnover |
-2
|
17
|
0 |
| Change turnover % |
-4%
|
34%
|
-1% |
| Chg. No. of employees |
-1
|
0
|
-1 |
| Chg. No. of employees % |
-100%
|
0%
|
-50% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.